Abstract
A systematic investigation of the parameters that affect the efficiency of immobilizing heparinase onto cyanogen bromide activated crosslinked 8% agarose beads was conducted. Two experimental measures, the “fraction bound” and the “fraction retained,” were used to monitor the coupling efficiency. The fraction bound is the portion of the total initial enzyme that is bound to the agarose gel. The fraction retained is the fraction of bound enzyme that is active. The product of the two measures indicates the coupling efficiency. The activity of the immobilized heparinase was measured under conditions free of both internal and external mass transfer limitations, and thus, the fraction retained represents the true immobilized enzyme activity.
Increasing the degree of activation of the beads results in an increase in the fraction bound, the fraction retained, and consequently, the coupling efficiency. As the ratio of enzyme solution to gel volume increases from 1.5 to 2.2, the fraction bound remains constant but the fraction retained decreases (heparinase concentration; 0.15 mg/mL and degree of activation; 9.5 μmol of cyanate esters/g of gel). At volume ratios greater than 2.2, both the fraction bound and the fraction retained decline continuously. Changing the heparinase concentration in the coupling solution changes the coupling efficiency in a manner similar to that of the volume ratio change.
When heparin is added during the coupling process, the fraction bound declines as the heparin concentration increases, whereas the fraction retained increases up to a heparin concentration of 12 mg/mL and decreases thereafter. When arginine, lysine, and glycine are used to block the unreacted cyanate ester groups after the coupling process, the immobilized heparinase shows different pH optima of 6.5, 6.9, and 7.2, respectively. Based upon these findings, a protocol to optimize heparinase immobilization is developed.
Similar content being viewed by others
References
Langer, R., Linhardt, R. J., Hoffberg, S., Larsen, A. K., Cooney, C. L., Tapper, D., and Klein, M. (1982),Science 217, 261.
Bernstein, H., Yang, V. C., Lund, D., Randawa, M., Harmon, W., and Langer, R. (1987),Kidney Int. 32, 452.
Bernstein, H., Yang, V. C., and Langer, R. (1987),Biotechnol. Bioeng. 30, 196.
Bernstein, H., Yang, V. C., and Langer, R. (1987),Biotechnol. Bioeng. 30, 239.
Linhardt, R.J., Cooney, C. L., Tapper, D., Zannetos, C. A., Larsen, A. K., and Langer, R. (1984),Appl. Biochem. Biotechnol. 9, 41.
Bradford, M. (1976),Anal. Biochem. 72, 248.
Linker, A. and Hovingh, P. (1972),Methods Enzymol. 28, 902.
Bernstein, H., Yang, V. C., Cooney, C. L., and Langer, R.Methods Enzymol. in press.
Wilchek, M. and Kohn, J. (1985),Anal. Biochem. 115, 375.
Galliher, P. M., Conway, L., Linhardt, R. J., Langer, R., and Cooney, C. L. (1982),Eur. J. Appl. Microb. 15, 252.
Yang, V. C, Linhardt, R. J., Bernstein, H., Cooney, C. L., and Langer, R. (1985),J. Biol. Chem. 260, 1849.
Yang, V. C., Bernstein, H., Cooney, C. L., and Langer, R.Appl. Biochem Biotechnol. in press.
March, S., Parikh, I., and Cuatrescass, P. (1974),Anal. Biochem. 60, 149.
Rosenberg, R. (1977),Semin. Hematol. 14, 427.
Goldstein, L. (1980),Methods Enzymol. 64, 398.
Enzyme Engineering 8 (1987), vol. 501, Laskin, A. I., Mosbach, K., Thomas, D., and Wingard, L. B., eds., Annals of the New York Academy of Science, New York.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bernstein, H., Yang, V.C. & Langer, R. An investigation of heparinase immobilization. Appl Biochem Biotechnol 16, 129–143 (1987). https://doi.org/10.1007/BF02798362
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02798362